63 results about "Benzalkonium chloride" patented technology

New liquid compositions are described for the relief of the xerostomia and the treatment of associated disorders, in which the compositions contain: a) saline saliva substitute agents selected from the group consisting of sodium chloride, potassium chloride, sodium bicarbonate, monobasic potassium phosphate, and dibasic phosphate potassium; b) saliva production stimulation agents selected from the group consisting of citric acid or its alkali metal salts and malic acid or its alkali metal salts; c) oral antiseptics selected from the group consisting of triclosan, chlorhexidine and its salts, benzalkonium and its salts, and cetylpyridinium chloride; d) anticariogenic agents selected from the group consisting of fluoride sodium, sodium monofluorophosphate, and xylitol; and e) oral mucosa protective agents selected from the group consisting of vitamin E acetate, panthenol, dipotassium glycyrrhizinate and extracts of aloe vera.The aforementioned compositions are presented in the form of mouthwashes, sprays, oral gels, and toothpastes.

The present invention provides an antiviral composition and system for using the same, wherein the antiviral composition includes between about 0.1 to about 0.3 wt % of antimicrobial agent such as benzalkoniumchloride, between about 0.1 to about 1 wt % of chlorinated phenol compound, such as parachlorometaxylenol, between about 0.1 to about 3 wt % of hydrogen peroxide, and at least about 60 wt % aqueous solvent.

Kits and methods for treating disordered tissue caused by a virus in a mammal involve co-administration of a systemic anti-virus drug and topically administering an anti-infective composition. The systemic anti-virus drug is internally administered and disrupts or inhibits virus replication systemically within the mammal. Examples include nucleoside analogues, nucleoside analogue precursors, and nucleotide analogues. The topically administered anti-infective composition includes at least one anti-infective agent, such as an organohalide (e.g., benzalkonium chloride), and is formulated to penetrate below the disordered tissue surface and allow the anti-infective agent to kill viruses at the disordered tissue site. The anti-infective composition reduces the time and / or number of dosages required for the systemic anti-virus drug to treat the disordered tissue in the absence of topically administering the anti-infective composition. It also reduces or eliminates incidences of post-treatment neuralgia.

The invention relates to eye drops suitable for corneal limbal stem cell deficiency and a preparation method. The eye drops comprise the following components: 1-40 mg / L of human adipose-derived stem cell exosome, and auxiliary materials including 0.5-2 g / L of sodium hyaluronate, 0.5-3 g / L of vitamin B6, 0.05-0.3 g / L of benzalkonium chloride and the balance of medical normal saline, and the pH value is 6.5-7.5. The eye drops provided by the invention have the remarkable effect of treating the corneal limbal stem cell deficiency.

There is provided according to the invention an aqueous composition having pH between 4 and 7 comprising (i) glucagon at a concentration of 0.05% w / v or more and (ii) a cationic surfactant selected from benzalkonium salts and benzethonium salts as solubilizing agent in an amount sufficient to dissolve the glucagon in the composition.

This invention relates to an improved smudge free sanitary sheet made of waste paper and a process of preparing the same through processing the surplus newsprint and mors precisely processing used / recycled paper. The sanitary sheets are prepared by the process steps of collecting pre -consumer overprint or post consumer read newspapers; grading the collected waste newspaper; drying and sterilizing the graded newspaper by applying ultraviolet, infrared and / or gamma rays; trimming and cutting the dried sterilized sheets in appropriate sizes; applying on atieast one of the sides of the waste newspaper an aqueous coating comprising of a mixture of resin such as bleached shellac, a dye, a germicide such as Benzaikonium Chloride (BC) and / or PCMX (Chloroxylenol), a safe colour, a known deodorant and optionally cosmetic chemicals such as emollient and a foaming agent such as a detergent.; The improved sanitary sheeets prepaid by the present cost effective invention has taken care of any toxic effect on human skin to make those hygenic and aesthetic and the discarded sheets being biodegradable, the present invention is environment friendly. The sanitary sheets from present invention has various wide applications such as a single use barrier in outpatient beds of clinics or on x-ray tables, safe paper bags for carrying dry stuff, a mat on a publicly used seat like gyrn, safe pet care , paper towel, toilet paper, sanitary napkin, child diapers, adult incontinence products etc.